Thrivent Financial for Lutherans Has $1.23 Million Stake in Cabot Co. (NYSE:CBT)

Thrivent Financial for Lutherans lowered its holdings in shares of Cabot Co. (NYSE:CBT) by 3.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,351 shares of the specialty chemicals company’s stock after selling 540 shares during the period. Thrivent Financial for Lutherans’ holdings in Cabot were worth $1,227,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CBT. Banque Cantonale Vaudoise boosted its position in shares of Cabot by 17.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 833 shares of the specialty chemicals company’s stock valued at $77,000 after acquiring an additional 124 shares in the last quarter. Miller Howard Investments Inc. NY grew its stake in shares of Cabot by 4.4% in the 2nd quarter. Miller Howard Investments Inc. NY now owns 3,162 shares of the specialty chemicals company’s stock valued at $291,000 after purchasing an additional 132 shares during the period. Los Angeles Capital Management LLC raised its holdings in shares of Cabot by 1.4% in the 1st quarter. Los Angeles Capital Management LLC now owns 10,851 shares of the specialty chemicals company’s stock worth $1,000,000 after buying an additional 145 shares in the last quarter. CWM LLC lifted its position in shares of Cabot by 60.6% during the 2nd quarter. CWM LLC now owns 416 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 157 shares during the period. Finally, Mercer Global Advisors Inc. ADV boosted its stake in Cabot by 0.4% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 42,185 shares of the specialty chemicals company’s stock valued at $3,876,000 after buying an additional 162 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Insider Transactions at Cabot

In related news, CFO Erica Mclaughlin sold 23,274 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the transaction, the chief financial officer now directly owns 59,814 shares in the company, valued at $5,968,839.06. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CFO Erica Mclaughlin sold 23,274 shares of the company’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the sale, the chief financial officer now owns 59,814 shares in the company, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Hobart Kalkstein sold 5,457 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $100.58, for a total value of $548,865.06. Following the transaction, the executive vice president now owns 61,688 shares in the company, valued at approximately $6,204,579.04. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 71,939 shares of company stock worth $7,308,812 in the last quarter. 3.07% of the stock is owned by company insiders.

Cabot Price Performance

CBT opened at $110.48 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. The stock has a market capitalization of $6.10 billion, a P/E ratio of 13.98, a price-to-earnings-growth ratio of 1.01 and a beta of 1.19. The company’s 50 day simple moving average is $102.45 and its 200-day simple moving average is $97.98. Cabot Co. has a one year low of $65.10 and a one year high of $113.12.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The business’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company earned $1.42 EPS. Sell-side analysts anticipate that Cabot Co. will post 7.07 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 30th were paid a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.56%. The ex-dividend date of this dividend was Friday, August 30th. Cabot’s dividend payout ratio (DPR) is presently 21.77%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CBT. JPMorgan Chase & Co. increased their price objective on Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. UBS Group decreased their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Finally, StockNews.com downgraded Cabot from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 24th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $101.75.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.